Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension

BACKGROUND: The angiotensin receptor antagonist fimasartan lowered blood pressure (BP) in a previous large population study. The purpose of this study was to evaluate whether fimasartan treatment for 3 months affects clinical and home BP variability in addition to reducing BP. METHODS: The study enr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drug Des Devel Ther
Egile Nagusiak: Shin, Mi-Seung, Kang, Dae Ryong, Kim, Changsoo, Cho, Eun Joo, Sung, Ki-Chul, Kang, Seok-Min, Kim, Dong-Soo, Joo, Seung Jae, Lee, Seung Hwan, Hwang, Kyung-Kuk, Park, Jeong Bae
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2016
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4862351/
https://ncbi.nlm.nih.gov/pubmed/27217724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S107433
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak